期刊文献+

芒果苷上调HepG2细胞膜蛋白MRP3和核受体PXR、CPF表达 被引量:8

Mangiferin up-regulates expression of membrane protein MRP3 and nuclear receptors PXR and CPF in HepG2 cells
下载PDF
导出
摘要 目的体外HepG2细胞培养观察芒果苷(mangiferin)对多耐药相关蛋白3(multidrug resistance-associate protein 3,MRP3)和核受体孕烷X受体(pregnane X receptor,PXR)、CYP7A启动子结合因子(CYP7A promoter-binding factor,CPF)表达的影响。方法用芒果苷刺激HepG2细胞72 h后,分别抽提细胞RNA、膜蛋白及核蛋白,采用半定量RT-PCR和蛋白免疫印迹检测膜转运蛋白MRP3和核受体PXR、CPF在转录与蛋白水平的表达变化。熊脱氧胆酸(ursode-oxycholic acid,UDCA)处理的HepG2细胞作为阳性对照、DMSO处理细胞为阴性对照。结果芒果苷可显著刺激HepG2细胞膜转运蛋白MRP3的mRNA(比阴性对照组高3.0倍,P<0.05)和蛋白(比阴性对照组高3.3倍,P<0.05)表达,其作用强于UDCA。芒果苷也可明显上调核受体PXR[mRNA水平增高1.7倍(P<0.05),蛋白水平增高3.7倍(P<0.01)]、CPF[mRNA水平增高2.1倍(P<0.05),蛋白水平增高4.9倍(P<0.05)]的表达。结论芒果苷刺激肝癌细胞HepG2细胞膜转运蛋白MRP3的表达上调可能与核受体PXR、CPF途径相关。 Objective To observe the effect of mangiferin on expressions of multidrug resistance-associated protein 3(MRP3),nuclear pregnane X receptor(PXR),and CYP7A promoter-binding factor(CPF) in HepG2 cells.Methods Total RNA and membrane or nuclear protein were extracted from HepG2 cells 72 h after treated with mangiferin.Expressions of PXR and CPF at transcription and protein levels were detected by semi-quantitative RT PCR and Western blotting,respectively.HepG2 cells treated with ursodeoxycholic acid(UDCA) and DMSO served as positive and negative controls,respectively.Results Mangiferin could significantly up-regulate the mRNA and protein expression of MRP3 in HepG2 cells.The mRNA and protein expression levels of MRP3 were 3-fold and 3.3-fold higher,respectively,in positive controls than in negative controls(P0.05).The effect of mangiferin was stronger than that of UDCA on the expression of MRP3(P0.05).Mangiferin up-regulated the expression levels of PXR and CPF(1.7-fold),mRNA of MRP3(3.7-fold),CPF(2.1-fold),and protein of MRP3(4.9-fold),respectively,in HepG2 cells(P0.05).Conclusion Mangiferin can up-regulate the expression of MRP3 in HepG2 cells,which may be related with PXR and PXR.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2011年第3期246-249,共4页 Journal of Third Military Medical University
基金 国家自然科学基金(30570842 30900678 81070320) 重庆市自然科学基金(CSTC2007BA5030) 重庆市科委中药产业"重构提升"行动专项(CSTC2010AB5068)~~
关键词 芒果苷 UDCA MRP3 PXR CPF mangiferin ursodeoxycholic acid multidrug resistance-associated protein 3 pregnane X receptor CYP7A promoter-binding factor
  • 相关文献

参考文献17

  • 1Seheffer G L, Kool M, de-Haas M, et al. Tissue distribution and induction of human muhidrug resistant protein 3 [ J]. Lab Invest, 2002, 82(2) : 193 -201.
  • 2Akita H, Suzuki H, Hirohashi T, et al. Transport activity of human MRP3 expressed in St9 cells: comparative studies with rat MRP3 [ J ]. Pharm Res, 2002, 19(1) : 34 -41.
  • 3Rau S, Autschbach F, Riedel H D, et al. Expression of the multidrug resistance proteins MRP2 and MRP3 in human cholangiocellular carcinomas[J]. Eur J Clin Invest, 2008, 38(2): 134 -142.
  • 4Hasegawa Y, Kishimoto S, Takahashi H, et al. Altered expression of MRP2, MRP3 and UGT2B1 in the liver affects the disposition of morphine and its glucuronide conjugate in a rat model of cbolestasis[J]. J Pharm Pharmacol, 2009, 61 (9) : 1205 - 1210.
  • 5Csanaky I L, Aleksunes L M, Tanaka Y, et al. Role of hepatic transporters in prevention of biie acid toxicity after partial hepatectomy in mice [ J ]. Am J Physiol Gastrointest Liver Physiol, 2009, 297 ( 3 ) : G419 - G433.
  • 6Liu Y H, Di Y M, Zhou Z W, et al. Muhidrug resistance-associated proteins and implications in drug development[J]. Clin Exp Pharmacol Physiol, 2010, 37(1): 115-120.
  • 7Csanaky I L, Aleksunes L M, Tanaka Y, et al. Role of hepatic transporters in prevention of bile acid toxicity after partial hepatectomy in mice [ J ]. Am J Physiol Gastrointest Liver Physiol, 2009, 297 ( 3 ) : G419 - G433.
  • 8Bohan A, Chen W S, Denson L A, et al. Tumor necrosis factor alphadependent up-regulation of Lrh-1 and Mrp3 ( Abcc3 ) reduces liver injury in obstructive choldstasis [ J ]. J Biol Chem, 2003, 278 ( 38 ) : 36688 - 36698.
  • 9Wagner M, Halilbasic E, Marschall H U, et al. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice[ J]. Hepatology, 2005, 42 (2) : 420 - 430.
  • 10Teng S, Piquette-Miller M. Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis [ J ]. Br J Pharmacol, 2007, 151(3): 367-376.

二级参考文献9

  • 1Gustav Paumgartner.Medical treatment of cholestatic liver diseases:From pathobiology to pharmacological targets[J].World Journal of Gastroenterology,2006,12(28):4445-4451. 被引量:13
  • 2KULLAK-UBLICK G A,STIEGER B,MEIER P J.Enterohepatic bile salt transporters in normal physiology and liver disease[J].Gastroenterology,2004,126(1):322-342.
  • 3BOHAN A,CHEN W S,DENSON L A,et al.Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis[J].J Biol Chem,2003,278(38):36688-36698.
  • 4BOYER J L.Nuclear receptor ligands:rational and effective therapy for chronic cholestatic liver disease?[J].Gastroenterology,2005,129(2):735-740.
  • 5KEITEL V,BURDELSKI M,WARSKULAT U,et al.Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis[J].Hepatology,2005,41(5):1160-1172.
  • 6CHEN J,RAYMOND K.Nuclear receptors,bile-acid detoxification,and cholestasis[J].Lancet,2006,367(9509):454-456.
  • 7WAGNER M,HALILBASIC E,MARSCHALL H U,et al.CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice[J].Hepatology,2005,42(2):420-430.
  • 8QATANANI M,MOORE D D.CAR,the continuously advancing receptor,in drug metabolism and disease[J].Curr Drug Metab,2005,6(4):329-339.
  • 9ABU J,BATUWANGALA M,HERBERT K,et al.Retinoic acid and retinoid receptors:potential chemopreventive and therapeutic role in cervical cancer[J].Lancet Oncol,2005,6(9):712-720.

共引文献7

同被引文献162

引证文献8

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部